TA

Tarique Azam

Active Director Director DIN 10269412
DIN 10269412 First appointment Aug 2023
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2023
Shareholding value •••• Premium profile

About Tarique Azam

Data last updated:

Tarique Azam is a Director at Tapsa Health Research Laboratory Private Limited (since 2023). Tapsa Health Research Laboratory Private Limited reported revenue of ₹2.4 Lakh (FY 2025).

DIN 10269412
Primary Designation Director
First Appointment 07 Aug 2023
Oldest Company Age 3 yrs
Largest company Tapsa Health Research Laboratory Private Limited · ₹2.4 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director07 Aug 20232023₹2.4 Lakh (FY 2025)Active

Board colleagues of Tarique Azam

NameDINCompanyDesignation
Nagma Perween10269413Tapsa Health Research Laboratory Private LimitedDirector

Directorship timeline

Open interactive timeline →
Tapsa Health Research Laboratory Private Limited
Premium access

Shareholding and investment profile for Tarique Azam

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Tarique Azam

Tarique Azam currently holds 1 directorship: Tapsa Health Research Laboratory Private Limited (Director, since 07 Aug 2023, revenue ₹2.4 Lakh (FY 2025)).

Tarique Azam was first appointed on 07 Aug 2023 as Director at Tapsa Health Research Laboratory Private Limited.

The current boards of Tarique Azam's companies include Nagma Perween (Tapsa Health Research Laboratory Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available